257 related articles for article (PubMed ID: 8315492)
21. Synthesis and transporter binding properties of 2,3-diphenyltropane stereoisomers. Comparison to 3beta-phenyltropane-2beta-carboxylic acid esters.
Chang AC; Burgess JP; Mascarella SW; Abraham P; Kuhar MJ; Carroll FI
J Med Chem; 1997 Apr; 40(8):1247-51. PubMed ID: 9111298
[TBL] [Abstract][Full Text] [Related]
22. Discovery of novel trisubstituted asymmetric derivatives of (2S,4R,5R)-2-benzhydryl-5-benzylaminotetrahydropyran-4-ol, exhibiting high affinity for serotonin and norepinephrine transporters in a stereospecific manner.
Zhang S; Zhen J; Reith ME; Dutta AK
J Med Chem; 2005 Jul; 48(15):4962-71. PubMed ID: 16033275
[TBL] [Abstract][Full Text] [Related]
23. Alterations of myocardial sympathetic innervation in response to hypoxia.
Scherrer-Crosbie M; Mardon K; Cayla J; Syrota A; Merlet P
J Nucl Med; 1997 Jun; 38(6):954-7. PubMed ID: 9189149
[TBL] [Abstract][Full Text] [Related]
24. Functional consequences of homo- but not hetero-oligomerization between transporters for the biogenic amine neurotransmitters.
Kocabas AM; Rudnick G; Kilic F
J Neurochem; 2003 Jun; 85(6):1513-20. PubMed ID: 12787070
[TBL] [Abstract][Full Text] [Related]
25. Molecular cloning and characterization of an L-epinephrine transporter from sympathetic ganglia of the bullfrog, Rana catesbiana.
Apparsundaram S; Moore KR; Malone MD; Hartzell HC; Blakely RD
J Neurosci; 1997 Apr; 17(8):2691-702. PubMed ID: 9092590
[TBL] [Abstract][Full Text] [Related]
26. Increased MIBG uptake after transfer of the human norepinephrine transporter gene in rat hepatoma.
Altmann A; Kissel M; Zitzmann S; Kübler W; Mahmut M; Peschke P; Haberkorn U
J Nucl Med; 2003 Jun; 44(6):973-80. PubMed ID: 12791828
[TBL] [Abstract][Full Text] [Related]
27. Restriction site-independent formation of chimeras from homologous neurotransmitter-transporter cDNAs.
Moore KR; Blakely RD
Biotechniques; 1994 Jul; 17(1):130-5, 137. PubMed ID: 7946295
[TBL] [Abstract][Full Text] [Related]
28. Effect of uptake-one inhibitors on the uptake of norepinephrine and metaiodobenzylguanidine.
Tobes MC; Jaques S; Wieland DM; Sisson JC
J Nucl Med; 1985 Aug; 26(8):897-907. PubMed ID: 3162008
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the sodium dependency of uptake of meta-lodobenzylguanidine and norepinephrine into cultured bovine adrenomedullary cells.
Jaques S; Tobes MC; Sisson JC; Baker JA; Wieland DM
Mol Pharmacol; 1984 Nov; 26(3):539-46. PubMed ID: 6493209
[TBL] [Abstract][Full Text] [Related]
30. Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis of monoamine transporters in neuroblastoma cell lines: correlations to meta-iodobenzylguanidine (MIBG) uptake and tyrosine hydroxylase gene expression.
Lode HN; Bruchelt G; Seitz G; Gebhardt S; Gekeler V; Niethammer D; Beck J
Eur J Cancer; 1995; 31A(4):586-90. PubMed ID: 7576974
[TBL] [Abstract][Full Text] [Related]
31. Selective inhibition of monoamine neurotransmitter transporters by synthetic local anesthetics.
Sato T; Kitayama S; Mitsuhata C; Ikeda T; Morita K; Dohi T
Naunyn Schmiedebergs Arch Pharmacol; 2000 Feb; 361(2):214-20. PubMed ID: 10685879
[TBL] [Abstract][Full Text] [Related]
32. Transporter-mediated actions of R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane.
Shimazu S; Tsunekawa H; Yoneda F; Katsuki H; Akaike A; Janowsky A
Eur J Pharmacol; 2003 Dec; 482(1-3):9-16. PubMed ID: 14659999
[TBL] [Abstract][Full Text] [Related]
33. Cell-type-specific expression of catecholamine transporters in the rat brain.
Lorang D; Amara SG; Simerly RB
J Neurosci; 1994 Aug; 14(8):4903-14. PubMed ID: 8046459
[TBL] [Abstract][Full Text] [Related]
34. Transmitter uptake and release in PC12 cells overexpressing plasma membrane monoamine transporters.
Schonn JS; Desnos C; Henry JP; Darchen F
J Neurochem; 2003 Feb; 84(4):669-77. PubMed ID: 12562511
[TBL] [Abstract][Full Text] [Related]
35. Ketamine inhibits monoamine transporters expressed in human embryonic kidney 293 cells.
Nishimura M; Sato K; Okada T; Yoshiya I; Schloss P; Shimada S; Tohyama M
Anesthesiology; 1998 Mar; 88(3):768-74. PubMed ID: 9523822
[TBL] [Abstract][Full Text] [Related]
36. Sodium dependency of uptake of norepinephrine and m-iodobenzylguanidine into cultured human pheochromocytoma cells: evidence for uptake-one.
Jaques S; Tobes MC; Sisson JC
Cancer Res; 1987 Aug; 47(15):3920-8. PubMed ID: 3607739
[TBL] [Abstract][Full Text] [Related]
37. Plasma membrane transporters of serotonin, dopamine, and norepinephrine mediate serotonin accumulation in atypical locations in the developing brain of monoamine oxidase A knock-outs.
Cases O; Lebrand C; Giros B; Vitalis T; De Maeyer E; Caron MG; Price DJ; Gaspar P; Seif I
J Neurosci; 1998 Sep; 18(17):6914-27. PubMed ID: 9712661
[TBL] [Abstract][Full Text] [Related]
38. Dopamine and norepinephrine transporter-dependent c-Fos production in vitro: relevance to neuroadaptation.
Yatin SM; Miller GM; Madras BK
J Neurosci Methods; 2005 Apr; 143(1):69-78. PubMed ID: 15763138
[TBL] [Abstract][Full Text] [Related]
39. Cotransfecting norepinephrine transporter and vesicular monoamine transporter 2 genes for increased retention of metaiodobenzylguanidine labeled with iodine 131 in malignant hepatocarcinoma cells.
Zhao Y; Zhong X; Ou X; Cai H; Wu X; Huang R
Front Med; 2017 Mar; 11(1):120-128. PubMed ID: 28213878
[TBL] [Abstract][Full Text] [Related]
40. Further characterisation of the interaction of haloperidol metabolites with neurotransmitter transporters in rat neuronal cultures and in transfected COS-7 cells.
Siebert GA; Pond SM; Bryan-Lluka LJ
Naunyn Schmiedebergs Arch Pharmacol; 2000 Mar; 361(3):255-64. PubMed ID: 10731037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]